March 10, 2016 — The article below, which covers drug pricing concerns in the news and the success of Merck’s Keytruda in treating President Jimmy Carter, is reprinted with permission by The RPM Report. According to Coalition for Healthcare Communication Executive Director John Kamp, “Drug innovation is expensive but worth it. Thank goodness that Jimmy […]
Read more